Judit Manchon-Nunez

Badalona, CT 08916, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Erratum: Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity.

Erratum: Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity.

Journal: iScience
Published: December 30, 2024

AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.

AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action.

Journal: Science advances
Published: October 09, 2024

Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity.

Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity.

Journal: iScience
Published: July 10, 2023

An Integrative Analysis of DNA Methylation Pattern in Myotonic Dystrophy Type 1 Samples Reveals a Distinct DNA Methylation Profile between Tissues and a Novel Muscle-Associated Epigenetic Dysregulation.

An Integrative Analysis of DNA Methylation Pattern in Myotonic Dystrophy Type 1 Samples Reveals a Distinct DNA Methylation Profile between Tissues and a Novel Muscle-Associated Epigenetic Dysregulation.

Journal: Biomedicines
Published: April 22, 2022

Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1.

Characterization of RAN Translation and Antisense Transcription in Primary Cell Cultures of Patients with Myotonic Dystrophy Type 1.

Journal: Journal of clinical medicine
Published: October 30, 2021

Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1.

Preliminary Findings on CTG Expansion Determination in Different Tissues from Patients with Myotonic Dystrophy Type 1.

Journal: Genes
Published: September 18, 2020

The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.

The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1.

Journal: Genes
Published: May 27, 2020

Three-dimensional imaging in myotonic dystrophy type 1: Linking molecular alterations with disease phenotype.

Three-dimensional imaging in myotonic dystrophy type 1: Linking molecular alterations with disease phenotype.

Journal: Neurology. Genetics
Published: February 21, 2020

A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotype.

A DM1 family with interruptions associated with atypical symptoms and late onset but not with a milder phenotype.

Journal: Human mutation
Published: August 21, 2018

Correction to: Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

Correction to: Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

Journal: Journal of inherited metabolic disease
Published: July 22, 2018

Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

Manifesting heterozygotes in McArdle disease: a myth or a reality-role of statins.

Journal: Journal of inherited metabolic disease
Published: January 31, 2018
Showing 1-11 of 11

Last Updated: 09/26/2026